CXCL8 and cancer: Lipopolysaccharide (LPS), a TLR4 agonist, can induce anti-inflammatory cytokine secretion (e.g., IL-8) by activating TLR4 expressed in cancer cells (Moghadam and Nowroozi, 2019; McCall et al., 2020).